Evaluation of novel candidate filtration markers from a global metabolomic discovery for glomerular filtration rate estimation.

filtration markers glomerular filtration rate metabolomics

Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
23 Nov 2023
Historique:
received: 24 05 2023
revised: 31 10 2023
accepted: 10 11 2023
pubmed: 26 11 2023
medline: 26 11 2023
entrez: 25 11 2023
Statut: aheadofprint

Résumé

Creatinine and cystatin-C are recommended for estimating glomerular filtration rate (eGFR) but accuracy is suboptimal. Here, using untargeted metabolomics data, we sought to identify candidate filtration markers for a new targeted assay using a novel approach based on their maximal joint association with measured GFR (mGFR) and with flexibility to consider their biological properties. We analyzed metabolites measured in seven diverse studies encompasing 2,851 participants on the Metabolon H4 platform that had Pearson correlations with log mGFR and used a stepwise approach to develop models to < -0.5 estimate mGFR with and without inclusion of creatinine that enabled selection of candidate markers. In total, 456 identified metabolites were present in all studies, and 36 had correlations with mGFR < -0.5. A total of 2,225 models were developed that included these metabolites; all with lower root mean square errors and smaller coefficients for demographic variables compared to estimates using untargeted creatinine. Seventeen metabolites were chosen, including 12 new candidate filtration markers. The selected metabolites had strong associations with mGFR and little dependence on demographic factors. Candidate metabolites were identified with maximal joint association with mGFR and minimal dependence on demographic variables across many varied clinical settings. These metabolites are excreted in urine and represent diverse metabolic pathways and tubular handling. Thus, our data can be used to select metabolites for a multi-analyte eGFR determination assay using mass spectrometry that potentially offers better accuracy and is less prone to non-GFR determinants than the current eGFR biomarkers.

Identifiants

pubmed: 38006943
pii: S0085-2538(23)00784-6
doi: 10.1016/j.kint.2023.11.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Auteurs

Nora Fino (N)

Division of Biostatistics, Department of Population Health Sciences, University of Utah Health, Salt Lake City, Utah, USA.

Ogechi M Adingwupu (OM)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.

Josef Coresh (J)

Department of Epidemiology, John Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Tom Greene (T)

Division of Biostatistics, Department of Population Health Sciences, University of Utah Health, Salt Lake City, Utah, USA.

Ben Haaland (B)

Division of Biostatistics, Department of Population Health Sciences, University of Utah Health, Salt Lake City, Utah, USA.

Michael G Shlipak (MG)

Kidney Health Research Collaborative, San Francisco Veterans Affair Medical Center and University of California, San Francisco, San Francisco, California, USA.

Veronica T Costa E Silva (VT)

Serviço de Nefrologia, Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil; Laboratório de Investigação Médica 16, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Roberto Kalil (R)

Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Ayse L Mindikoglu (AL)

Margaret M. and Albert B. Alkek Department of Medicine, Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA; Michael E. DeBakey Department of Surgery, Division of Abdominal Transplantation, Baylor College of Medicine, Houston, Texas, USA.

Susan L Furth (SL)

Department of Pediatrics, Children's Hospital of Philadelphia, and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Jesse C Seegmiller (JC)

Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.

Andrew S Levey (AS)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.

Lesley A Inker (LA)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA. Electronic address: linker@tuftsmedicalcenter.org.

Classifications MeSH